---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-066418"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:05:25.937282+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics regains Nasdaq annual meeting compliance

## Summary
- Received Nasdaq letter confirming compliance with Listing Rule 5620(a) after holding Annual Meeting on June 30, 2025.
- Matter is now closed; no further action required from Nasdaq.
- Company had previously reported the meeting in a Form 8-K filed July 2, 2025.

## SEC filing metadata
- accession: 0001104659-25-066418
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925066418/0001104659-25-066418-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925066418/tm2520095d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-066418
- JSON: https://secwatch.observer/filing/0001104659-25-066418.json
- Plain text: https://secwatch.observer/filing/0001104659-25-066418.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.